In vivo modelling of coagulation factor concentrate thrombogenicity
MacGregor, I.; Drummond, O.; Prowse, C.
Thrombosis and Haemostasis 77(2): 405-406
1997
ISSN/ISBN: 0340-6245 PMID: 9157607 Document Number: 477448
Document emailed within 1 workday
Related Documents
Aronson, D.L.; Menache, D. 1987: Thrombogenicity of factor IX complex: in vivo investigation Developments in Biological Standardization 67: 149-155Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Smit Sibinga, C.T.; Daenen, S.M.; van Imhoff, G.W.; Maas, A.; Das, P.C. 1984: Heparin small pool high yield purified factor VIII: in vivo recovery and half-life of routinely produced freeze-dried concentrate Thrombosis and Haemostasis 51(1): 12-15
Ashkinazi, I.I.; Klemina, I.K. 1970: The effect of activated Hageman factor on the blood coagulation system in vivo Biulleten' Eksperimental'noi Biologii i Meditsiny 69(4): 32-36
Lixfeld, W.; MacGregor, D.C. 1974: In vivo evaulation of the thrombogenicity of suture materials Surgical Forum 25(0): 427-429
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Lusher, J.M. 1991: Thrombogenicity associated with factor IX complex concentrates Seminars in Hematology 28(3 Suppl 6: 3-5
Philippou, H.; Adami, A.; Lane, D.A.; MacGregor, I.R.; Tuddenham, E.G.; Lowe, G.D.; Rumley, A.; Ludlam, C.A. 1996: High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC Thrombosis and Haemostasis 76(1): 23-28
Schricker, K.T.; Neidhardt, B. 1981: Gastrectomy in congenital factor VIi deficiency with substitution of factor VIi concentrate Medizinische Klinik 76(19): 534-536
Prowse, C.V.; Chirnside, A.; Elton, R.A. 1980: In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays Thrombosis and Haemostasis 42(5): 1355-1367
Chaballe, L.; Schoenen, J.; Franzen, R. 2011: Placental growth factor: a tissue modelling factor with therapeutic potentials in neurology? Acta Neurologica Belgica 111(1): 10-17
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266
Andes, W.A. 1983: Factor VIIi concentrate--hepatitis JAMA 249(17): 2331
Suomela, H.; Myllylä, G. 1971: A factor IX-concentrate for the treatment of haemophilia B Duodecim; Laaketieteellinen Aikakauskirja 87(1): 31-38
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Allain, J.P.; Steinbuch, M.; Meunier, L.; Muller, J.Y.; Soulier, J.P. 1976: Substitutive treatment of hemopjolia a using a new factor VIIi concentrate La Nouvelle Presse Medicale 5(16): 1047-1050
Simonetti, C.; Casillas, G.; Farías, C.; De los Santos, J.C. 1981: A new human factor VIIi concentrate. Preparation and clinical use Medicina 41 Suppl: 249-252